Actinium Pharmaceuticals Inc entered the industry of in 2000 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 3254120, which describes it as a . For further clarification, the SIC classifies this business under the code 8069 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Sergio Traversa, Chief Executive Officer by calling (646) 459-4201 during business hours. You can also write to the business’ Headquarters at 501 5th Avenue # 3, New York City, New York NY 10017. You can also visit the company’s website at actiniumpharmaceuticals.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Actinium Pharmaceuticals Inc |
| Representative: | Sergio Traversa, Chief Executive Officer |
| Place of Business: | 501 5th Avenue # 3, New York City, NY 10017 |
| Contact Number: | (646) 459-4201 |
| Website: | actiniumpharmaceuticals.com |
| Type of Service: | |
| SIC Number: | 8069 |
| NAICS Number: | 3254120 |
| Locality: | Headquarters |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2000 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Actinium Pharmaceuticals Inc is a company operating from New York, New York providing professional and relevant B2C variables. It was founded in 2000 and registered with the SIC code 8069 as , and with the NAICS code 3254120 as .
With a current employee count of 1 to 4, Actinium Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Sergio Traversa, Chief Executive Officer at (646) 459-4201 for related queries, or to locate its Headquarters using the coordinates 40.753438,-73.980838.
The Headquarters can also be found at the street address 501 5th Avenue # 3 in New York City, New York 10017 and can be engaged online through the company website at actiniumpharmaceuticals.com, the company Twitter , and Facebook page .